Report an adverse effect

From Research
to Reality

Next-generation medications. Commitment to excellence,
building trust – these are modern solutions for everyone’s health.

Pain Treatment

Pain treatment is a complex field of medicine that requires the use of various methods. As a leading manufacturer of analgesics,
we provide effective solutions to meet these challenges.

ANESTHESIOLOGY

One of the most important therapeutic areas for Molteni Farmaceutici is anesthetics,
where the company has invested significant resources to ensure the high quality of the production process.

Addiction Therapy

The ability to innovate and stay ahead of the times, the passion for research, and the skill in applying scientific advancements
and advanced technologies in the pharmaceutical industry are our secrets to success.

Diabetes Control

The ability to innovate and stay ahead of the times, the passion for research, and the skill in applying scientific advancements
and advanced technologies in the pharmaceutical industry are our secrets to success.

Italian Precision
Since 1892

The ability to innovate and stay ahead of the times, the passion for research, and the skill in applying scientific advancements
and advanced technologies in the pharmaceutical industry are our secrets to success.

In Poland
Since 1994

Molteni Farmaceutici Polska Sp. z o.o. was founded in 1994 in Krakow
and is the first foreign investment of the company L. Molteni & C. dei F.lli Alitti, active in Italy since 1892.

1892

year

History

Our story begins in Florence. The origins of Molteni Farmaceutici date back to 1892. In this year, the company’s now-historic headquarters was established, complete with a pharmacy in the center of Florence. Here, Alfredo Alitti, a young chemist from the Marche region, created a laboratory. Later, together with his brother Aurelio, he began manufacturing medicines.

At the turn of the 1900s, Molteni had already become a significant pharmaceutical company producing medicines according to its own patented procedures. The products created at that time were intended for parenteral administration.

Today, the Italian Molteni facilities cover an area of 10,000 square meters on the outskirts of Florence. This site is home to the company’s headquarters, Research and Development Department, and the department responsible for Italian and international marketing, along with numerous research laboratories.

Visit the website

Molteni Farmaceutici Polska Sp. z o.o. was established in 1994 in Kraków as the first foreign investment of L. Molteni & C. dei F.lli Alitti, which has operated in Italy since 1892.

At the start of its operations, Molteni Farmaceutici Polska was a pharmaceutical wholesaler selling Molteni group products. A manufacturing facility was set up in Kraków to produce liquid formulations, compliant with Good Manufacturing Practice (GMP) guidelines.

Currently, Molteni Farmaceutici Polska conducts informational, promotional, and educational activities related to medications throughout Poland. The company oversees pharmacotherapy safety (pharmacovigilance).

Molteni Farmaceutici Polska operates in three therapeutic areas: pain management, anesthesiology, and substitution therapy. In each area, it provides doctors with the most modern solutions, both in terms of therapeutic substances used and in the technology of the medicines themselves.

Mission

and Values

Values

Our mission is to enhance global well-being by prioritizing individual health. We advance medical research and develop innovative solutions for pain management and addiction treatment, ensuring high-quality care, and empowering patients to reclaim their lives back.

We are dedicated to driving innovation in pharmaceuticals to create transformative, data-driven, and evidence-based solutions that are valuable for patients and healthcare providers. Our vision is to lead the future of healthcare by developing cutting-edge treatments that improve quality of life and contribute to the equality and sustainability of the healthcare ecosystem.

Board of Directors

Zbigniew Brydak

Chairman of the Board of Directors

Federico Seghi Recli

Vice Chairman of the Board of Directors

Justyna Kowal-Sobczyk

Member of the Board of Directors

Therapeutic Areas

One of the main areas of focus for Molteni Farmaceutici, where the company can boast significant achievements, is the field of anesthetic and pain-relief medications. The company’s substantial investments in this area have fully ensured the quality standards of production and the high effectiveness of the products, whose variety meets all therapeutic needs.

Focusing on development, Molteni Farmaceutici leverages daily advancements in chemical, pharmaceutical, and medical sciences to develop new drugs and apply them effectively in therapy. The primary goal is to develop treatment methods that can improve patients’ quality of life and ensure better therapeutic outcomes. The production and quality control departments are equipped with the most advanced technology.

Pain treatment, addiction therapy, and anesthetic drugs are therapeutic areas where Molteni Farmaceutici is a leader in Europe.

Molteni was the first
to introduce ropivacaine
to the Polish market.

Addiction is a chronic
disease of the central
nervous system …

Diabetes is a group of
metabolic diseases, characterized
by a common feature …

Every patient has the
right to live without pain.
The law protects and guarantees …

CAREER

We are looking for talented and growth-oriented professionals.
We consider only the knowledge, experience, and skills of both candidates and employees.

We need exceptional individuals for an exceptional team, where we provide all employees with essential training and equal opportunities.

MOLTENI FARMACEUTICI POLSKA Sp. z o.o.
ul. Korzeniowskiego 39,
30-214 Kraków

Contact
Visit the website